| Detected | Trial | Change |
|---|---|---|
| 2026-07-29 | NCT05666700 CAR-T Cell Therapy in RelApsed/Refractory Myeloma With ExtrameduLlary Disease - an in… |
Enrollment closed, study ongoing |
| 2026-07-29 | NCT05666700 CAR-T Cell Therapy in RelApsed/Refractory Myeloma With ExtrameduLlary Disease - an in… |
date change Primary completion pushed: 2026-01 -> 2027-01 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT05154162 | PSMA PET Additive Value for Prostate Cancer Diagnosis in Men With Negative/Equivocal MRI | Prostate Cancer | Active, Not Recruiting |
| Phase 2 | |||
| NCT06414148 | MRD-Directed Consolidation With Epcor-only or Epcor-R2 Post Anti-CD19 CAR TCell Therapy… | Relapsed/Refractory Large B-cell Lymphoma | Recruiting |
| NCT05560659 | Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative… | Oligometastatic Prostate Cancer | Recruiting |
| NCT06812715 | Clonal Dynamics of Chronic Lymphocytic Leukaemia Treated With Pirtobrutinib After… | Chronic Lymphocytic Leukemia | Recruiting |
| NCT07217938 | Novel Treatment of Radiation Associated Dysphagia With Statins | Radiation-associated Dysphagia | Recruiting |
| NCT05864742 | Genetically Risk-Stratified Venetoclax, Ibrutinib, Rituximab (± Navitoclax) in… | Mantle Cell Lymphoma Refractory | Active, Not Recruiting |
| NCT04234061 | Clinical Trial to Assess The Efficacy and Safety of the Combination of Tisagenlecleucel… | Mantle Cell Lymphoma Recurrent | Active, Not Recruiting |
| NCT05878288 | Deep sequencIng in Cutaneous Squamous CEll caRciNomas | Cutaneous Squamous Cell Carcinoma | Active, Not Recruiting |
| NCT04343885 | In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177… | Metastatic Hormone Naive Prostate Cancer | Active, Not Recruiting |
| NCT05095519 | Hepatocellular Carcinoma Imaging Using PSMA PET/CT | Hepatocellular Carcinoma | Active, Not Recruiting |
| NCT07434180 | Phase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary | Cancer of Unknown Primary | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT05521412 | EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate… | Prostate Cancer | Recruiting |
| NCT03980171 | Study of Lenalidomide, Venetoclax and Obinutuzumab in Patients With Treatment-Naïve… | Follicular Lymphoma | Active, Not Recruiting |
| NCT04914741 | A Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and… | Diffuse Large B Cell Lymphoma | Active, Not Recruiting |
| NCT04430192 | Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy | Prostatic Neoplasms | Active, Not Recruiting |
| NCT05383079 | Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men with Metastatic… | Metastatic Castration-resistant Prostate Cancer | Active, Not Recruiting |
| NCT05340374 | Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant… | Metastatic Castration-resistant Prostate Cancer | Active, Not Recruiting |
| Phase 1 | |||
| NCT05222087 | PRIME_LUNG: Primary Radiotherapy In MEtastatic Lung Cancer - A Pilot Study | NSCLC | Recruiting |
| NCT05053854 | PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours | Neuroendocrine Tumors | Recruiting |
| NCT07541391 | Autologous Chimeric Antigen Receptor (CAR) T-cells Targeting the Kappa Myeloma Antigen… | Relapsed/Refractory Multiple Myeloma | Recruiting |
| NCT03900884 | Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer | Breast Neoplasm Female | Active, Not Recruiting |
| NCT03874884 | 177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant… | Metastatic Castration Resistant Prostate Cancer (mCRPC) | Active, Not Recruiting |
| NCT07090369 | Phase Ib Trial of 177Lu-PSMA-I&T Therapy in Combination With Olaparib and Pembrolizumab… | Metastatic Castrate Resistant Prostate Cancer (mCRPC) | Not Yet Recruiting |
| NCT05666700 | CAR-T Cell Therapy in RelApsed/Refractory Myeloma With ExtrameduLlary Disease - an in… | Extramedullary Myeloma | Active, Not Recruiting |
| Not specified | |||
| NCT05570227 | Metabolic Phenotypes in Melanoma | Melanoma | Recruiting |